Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2005
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227253 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227243 Cell cycle progression proteins
10/13/2005US20050227238 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
10/13/2005US20050227237 Human neuronal attachment factor-1
10/13/2005US20050226942 A combination of Bacopa monniera extract, milk thistle extract, ashwagandha powder, green tea extract, and turmeric extract increases the enzyme activity level of superoxide dismutase and catalase and decreases the plasma concentration level of thiobarbituric acid reactive chemical species
10/13/2005US20050226940 Antitumour compositions containing taxane derivatives
10/13/2005US20050226934 Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
10/13/2005US20050226895 vaccine to protect salmon against infection by Piscirickettsia salmonis, a gramnegative bacteria; salmonid rickettsial septicaemia
10/13/2005US20050226893 Lyophilization method to improve excipient crystallization
10/13/2005US20050226891 Multiple antigenic peptides immunogenic against Streptococcus pneumonia
10/13/2005US20050226885 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
10/13/2005US20050226882 Method and multicomponent conjugates for treating cancer
10/13/2005US20050226881 Isolated peptide which binds to HLA-Cw*07 and uses thereof
10/13/2005US20050226871 Using mixture of fk-506 and geldanamycin compound immobilized onto polypeptide; both compounds bind to polypeptide components of steroid receptor complexes, hsp90 and FKBP52, respectively
10/13/2005US20050226870 Administering anti-inflammatory amount of a purified antibody specific against C5, wherein antibody inhibits the cleavage of C5 into C5a and C5b
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226862 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders and for identifying agents therapeutic therefor
10/13/2005US20050226860 Defense and counter-defense compositions and methods
10/13/2005US20050226859 Peg-Modified Uricase
10/13/2005US20050226858 Compositions containing reduced coenzyme Q10 and carotenoid
10/13/2005US20050226857 T cell therapy for the treatment of cachexia and chronic diseases
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226845 Oral administration of a daily dosage of greater than 5x108 Units of interferon tau for treating a disease or condition responsive to interleukin-10 therapy, such as Alzheimer's disease, liver or pulmonary fibrosis, autism, COPD, organ transplant rejection, antiphospholipid syndrome, and atherosclerosis
10/13/2005US20050226843 Polymer-based compositions and conjuates of HIV entry inhibitors
10/13/2005US20050226822 Oral care products containing ovomucin
10/13/2005US20050226821 Cosmetic formulations containing l-arginine oligomers
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005US20050226812 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/13/2005DE102004011687A1 VGLUT-spezifische dsRNA-Verbindungen VGLUT-specific dsRNA compounds
10/13/2005CA2847454A1 Method for modification of nmda receptors through inhibition of src
10/13/2005CA2602596A1 Compositions and methods for improved mucus function
10/13/2005CA2594927A1 Hunter-killer peptides and methods of use
10/13/2005CA2563117A1 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
10/13/2005CA2563103A1 Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer
10/13/2005CA2561835A1 Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors
10/13/2005CA2561577A1 Therapeutic use of a growth factor, nsg33
10/13/2005CA2561530A1 Therapeutic or prophylactic agent for arthritis
10/13/2005CA2561376A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
10/13/2005CA2561317A1 Bmp-3 propeptides and related methods
10/13/2005CA2560906A1 Method for modification of nmda receptors through inhibition of src
10/13/2005CA2560826A1 Antioxidant-promoting herbal extract compositions for alleviating oxidative stress in a mammal
10/13/2005CA2560618A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005CA2560011A1 Cospeptin, cosmedin and their uses
10/13/2005CA2559853A1 Materials and methods for treatment of inflammatory and cell proliferation disorders
10/13/2005CA2558754A1 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
10/13/2005CA2558615A1 Azabicyclo-octane inhibitors of iap
10/13/2005CA2557061A1 Factor ixa for the treatment of bleeding disorders
10/13/2005CA2556227A1 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
10/12/2005EP1584686A1 Progenitor cell preservation factors and related methods and products
10/12/2005EP1584685A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
10/12/2005EP1584682A1 Regulation of bcl-2 gene expression
10/12/2005EP1584681A2 Antisense oligonucleotide sequences as inhibitors of microorganisms
10/12/2005EP1584628A2 Viral protein
10/12/2005EP1584624A1 A full-length polynucleotide coding chicken type ii collagen and the use of it
10/12/2005EP1584623A1 A group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof
10/12/2005EP1583986A2 Biomedical devices with antimicrobial coatings
10/12/2005EP1583844A2 Modulation of pten expression via oligomeric compounds
10/12/2005EP1583836A2 METHOD OF INTRODUCING siRNA INTO ADIPOCYTES
10/12/2005EP1583833A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof
10/12/2005EP1583832A2 Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
10/12/2005EP1583828A1 Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders
10/12/2005EP1583824A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
10/12/2005EP1583817A2 Active variants of fgf with improved specificity
10/12/2005EP1583816A2 Protein arrays
10/12/2005EP1583774A2 Methods for preventing and treating alzheimer's disease (ad)
10/12/2005EP1583773A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof
10/12/2005EP1583772A2 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
10/12/2005EP1583587A2 Organic compounds with biological action as thrombin inhibitors and use therof
10/12/2005EP1583568A2 Biomedical devices with peptide containing coatings
10/12/2005EP1583557A2 Vaccine compositions and methods
10/12/2005EP1583555A1 Use of somatostatin analogs in sleep apnea
10/12/2005EP1583554A2 Use of natriuretic peptides for the treatment of stature disorders related to the shox gene
10/12/2005EP1583553A2 Therapeutic use of modulators of notch
10/12/2005EP1583552A2 Antineoplastic ether lipid compounds
10/12/2005EP1583551A1 Composition for preventing the formation of new scar comprising bmp-7
10/12/2005EP1583550A2 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
10/12/2005EP1583549A2 Peptide yy analogs
10/12/2005EP1583548A2 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
10/12/2005EP1583545A2 Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy
10/12/2005EP1583541A2 Compounds and methods for increasing neurogenesis
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1583422A2 Cell-based therapies for ischemia
10/12/2005EP1511765A4 Par-2-activating peptide derivative and pharmaceutical composition using the same
10/12/2005EP1511510B1 Use of uk114 in the treatment of leishmaniasis
10/12/2005EP1483561A4 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor
10/12/2005EP1478362B1 A combination treatment for acute myocardial infarction
10/12/2005EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof
10/12/2005EP1427829A4 Multivalent protein conjugate with multiple ligand-binding domains of receptors
10/12/2005EP1419174A4 Process for preparing glycopeptide derivatives
10/12/2005EP1294918B1 Replication deficient adenoviral tnf vector
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1231886A4 Topical skin composition
10/12/2005EP1212106B1 Phospholipid-coated implants
10/12/2005EP1185293B1 Il6ril6 chimera for the treatment of neurodegenerative diseases
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP0904094B1 Treatment of bone disorders with adrenomedullin
10/12/2005EP0818462B1 Glu-trp comprising tripeptides
1 ... 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 ... 3163